These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38262643)

  • 1. Outpatient paracentesis for the management of ovarian hyperstimulation syndrome: study protocol for the STOP-OHSS randomised controlled trial.
    White DA; Pye C; Ridsdale K; Dimairo M; Mooney C; Wright J; Young TA; Cheong YC; Drakeley A; Mathur R; O'Cathain A; Desoysa L; Sizer A; Lumley E; Chatters R; Metwally M
    BMJ Open; 2024 Jan; 14(1):e076434. PubMed ID: 38262643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volume expanders for the prevention of ovarian hyperstimulation syndrome.
    Youssef MA; Mourad S
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001302. PubMed ID: 27577848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient management of severe ovarian hyperstimulation syndrome: a systematic review and a review of existing guidelines.
    Gebril A; Hamoda H; Mathur R
    Hum Fertil (Camb); 2018 Jun; 21(2):98-105. PubMed ID: 28554223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine agonists for preventing ovarian hyperstimulation syndrome.
    Tang H; Mourad S; Zhai SD; Hart RJ
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008605. PubMed ID: 27901279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis.
    Smith LP; Hacker MR; Alper MM
    Fertil Steril; 2009 Dec; 92(6):1953-9. PubMed ID: 18976762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost analysis model of outpatient management of ovarian hyperstimulation syndrome with paracentesis: "tap early and often" versus hospitalization.
    Csokmay JM; Yauger BJ; Henne MB; Armstrong AY; Queenan JT; Segars JH
    Fertil Steril; 2010 Jan; 93(1):167-73. PubMed ID: 18990389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine agonists for preventing ovarian hyperstimulation syndrome.
    Tang H; Mourad SM; Wang A; Zhai SD; Hart RJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD008605. PubMed ID: 33851429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ounce of prevention: outpatient management of the ovarian hyperstimulation syndrome.
    Fluker MR; Copeland JE; Yuzpe AA
    Fertil Steril; 2000 Apr; 73(4):821-4. PubMed ID: 10731547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elective freezing of embryos versus fresh embryo transfer in IVF: a multicentre randomized controlled trial in the UK (E-Freeze).
    Maheshwari A; Bell JL; Bhide P; Brison D; Child T; Chong HY; Cheong Y; Cole C; Coomarasamy A; Cutting R; Hardy P; Hamoda H; Juszczak E; Khalaf Y; Kurinczuk JJ; Lavery S; Linsell L; Macklon N; Mathur R; Pundir J; Raine-Fenning N; Rajkohwa M; Scotland G; Stanbury K; Troup S; Bhattacharya S
    Hum Reprod; 2022 Mar; 37(3):476-487. PubMed ID: 34999830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.
    D'Angelo A; Amso NN; Hassan R
    Cochrane Database Syst Rev; 2017 May; 5(5):CD002811. PubMed ID: 28535578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
    Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
    Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
    McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
    Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous abdominal paracentesis for management of late type severe ovarian hyperstimulation syndrome.
    Chan CC; Yin CS; Lan SC; Chen IC; Wu GJ
    J Chin Med Assoc; 2004 Apr; 67(4):197-9. PubMed ID: 15244020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a progestin-primed ovarian stimulation protocol with a flexible GnRH antagonist protocol in patients with polycystic ovary syndrome who are participating in an IVF programme: study protocol for a randomised controlled trial.
    Wang N; Zhu Q; Ma M; Liang Z; Tao Y; Wang Y; Kuang Y
    BMJ Open; 2020 Dec; 10(12):e038153. PubMed ID: 33268401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy outcomes in patients with late-onset severe OHSS following different methods of ascetic fluid drainage and a comparison with non-OHSS IVF patients.
    Ren Y; Li R; Yang S; Yang R; Song D
    Arch Gynecol Obstet; 2022 Jun; 305(6):1587-1594. PubMed ID: 35059793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embryo freezing for preventing Ovarian Hyperstimulation Syndrome.
    D'Angelo A; Amso N
    Cochrane Database Syst Rev; 2002; (2):CD002806. PubMed ID: 12076453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.